Humira Buyers Ask 7th Circ. To Revive 'Patent Thicket' Case

By Matthew Perlman · October 6, 2020, 8:16 PM EDT

Humira buyers have urged the Seventh Circuit to revive their suit claiming AbbVie built an anti-competitive "patent thicket" around its blockbuster immunosuppressant drug Humira to keep cheaper biosimilars from coming to...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

Mayor and City Council of Baltimore, et al v. AbbVie Inc., et al

Case Number

Court

Appellate - 7th Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 30, 2020

Recent Articles By Matthew

June 24, 2024
Justices Won't Hear Objections To $2.67B BCBS Deal
June 10, 2024
Health Data Co. Says Rival's Request Risks Patient Security
June 04, 2024
Nurse Staffing Exec Wants Antitrust, Fraud Charges Separated
May 28, 2024
HIV Drug Buyers Fight Bid To Combine 9th Circ. Appeal Briefs
May 24, 2024
Software-Aided Price Fixing Under Antitrust Assault
May 16, 2024
Gilead, Teva Want 17 HIV Drug Antitrust Appeals Consolidated
May 13, 2024
2nd Circ. Affirms Dismissal Of Bystolic Antitrust Suit
May 07, 2024
MultiPlan, Insurance Cos. Accused Of Algorithmic Collusion
May 06, 2024
Biotech Co. Wants To Appeal Red Cross Antitrust Immunity
May 02, 2024
Lawmaker Wants Antitrust Probe Of Health Insurance Data Co.